476 related articles for article (PubMed ID: 15032590)
1. Immunity to tuberculosis.
North RJ; Jung YJ
Annu Rev Immunol; 2004; 22():599-623. PubMed ID: 15032590
[TBL] [Abstract][Full Text] [Related]
2. Restoration of innate immune activation accelerates Th1-cell priming and protection following pulmonary mycobacterial infection.
Lai R; Jeyanathan M; Shaler CR; Damjanovic D; Khera A; Horvath C; Ashkar AA; Xing Z
Eur J Immunol; 2014 May; 44(5):1375-86. PubMed ID: 24519467
[TBL] [Abstract][Full Text] [Related]
3. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
Salgame P
Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
[TBL] [Abstract][Full Text] [Related]
4. Promotion of a down-modulated lung immune state may be a strategy by M. tuberculosis to foster active disease and persistence.
Ho JL; Lapa e Silva JR
Discov Med; 2010 Jan; 9(44):34-41. PubMed ID: 20102683
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence.
Ríos-Barrera VA; Campos-Peña V; Aguilar-León D; Lascurain LR; Meraz-Ríos MA; Moreno J; Figueroa-Granados V; Hernández-Pando R
Eur J Immunol; 2006 Feb; 36(2):345-53. PubMed ID: 16421947
[TBL] [Abstract][Full Text] [Related]
7. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
9. Animal models of tuberculosis.
Gupta UD; Katoch VM
Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
[TBL] [Abstract][Full Text] [Related]
10. Differences in the ability to generate type 1 T helper cells need not determine differences in the ability to resist Mycobacterium tuberculosis infection among mouse strains.
Jung YJ; Ryan L; LaCourse R; North RJ
J Infect Dis; 2009 Jun; 199(12):1790-6. PubMed ID: 19426112
[TBL] [Abstract][Full Text] [Related]
11. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
12. Suppressed induction of mycobacterial antigen-specific Th1-type CD4+ T cells in the lung after pulmonary mycobacterial infection.
Yahagi A; Umemura M; Tamura T; Kariyone A; Begum MD; Kawakami K; Okamoto Y; Hamada S; Oshiro K; Kohama H; Arakawa T; Ohara N; Takatsu K; Matsuzaki G
Int Immunol; 2010 Apr; 22(4):307-18. PubMed ID: 20167585
[TBL] [Abstract][Full Text] [Related]
13. Mincle is not essential for controlling Mycobacterium tuberculosis infection.
Heitmann L; Schoenen H; Ehlers S; Lang R; Hölscher C
Immunobiology; 2013 Apr; 218(4):506-16. PubMed ID: 22784441
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice.
Korf H; Vander Beken S; Romano M; Steffensen KR; Stijlemans B; Gustafsson JA; Grooten J; Huygen K
J Clin Invest; 2009 Jun; 119(6):1626-37. PubMed ID: 19436111
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: Experimental tuberculous cavities].
Tsuyuguchi I
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1710-2. PubMed ID: 12170731
[No Abstract] [Full Text] [Related]
17. GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine.
Yang C; He YL; Zhang L; Xu L; Yi Z; Wang Y; Li N; Zhu D
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1360-6. PubMed ID: 19861007
[TBL] [Abstract][Full Text] [Related]
18. Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-gamma production.
Vesosky B; Flaherty DK; Rottinghaus EK; Beamer GL; Turner J
Exp Gerontol; 2006 Nov; 41(11):1185-94. PubMed ID: 17029663
[TBL] [Abstract][Full Text] [Related]
19. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection.
Bhatt K; Uzelac A; Mathur S; McBride A; Potian J; Salgame P
J Immunol; 2009 Mar; 182(6):3793-800. PubMed ID: 19265158
[TBL] [Abstract][Full Text] [Related]
20. Profiling early lung immune responses in the mouse model of tuberculosis.
Kang DD; Lin Y; Moreno JR; Randall TD; Khader SA
PLoS One; 2011 Jan; 6(1):e16161. PubMed ID: 21249199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
